Pacific Biosciences of California, Inc.
- Stock
- Ticker PACB
- ISIN US69404D1081
- Nasdaq
Performance, volatility and drawdowns of Pacific Biosciences of California, Inc. since 11/2016, with distributions reinvested and calculated in US dollars. As of 20 Nov 2026.
Performance
$10,000 grew to $2,071. Global equities (VT): $29,042.
Distributions reinvested, before taxes and brokerage costs. Dashed: Global equities (VT) for comparison.
Declines from the peak
Lowest point −98.2% in 05/2025, measured from the peak in 02/2021. The old peak has not been reached again yet.
Financial statements
Amounts in $ millions from filings with the SEC, earnings per share in $; fourth quarter and quarterly cash flow derived from year-to-date figures
| Quarter end | 12/2024 | 03/2025 | 06/2025 | 09/2025 | 12/2025 | 03/2026 | 06/2026 | 09/2026 |
|---|---|---|---|---|---|---|---|---|
| Income statement | ||||||||
| Revenue | 39 | 37 | 40 | 38 | 45 | 37 | 39 | 41 |
| Gross profit | 10 | -1.4 | 15 | 16 | 17 | 13 | 13 | 13 |
| Operating income | -153 | -429 | -45 | -39 | -41 | -8.4 | -45 | -37 |
| EBITDA | -150 | -424 | -42 | -36 | -38 | -6.2 | -42 | -35 |
| Net income | 2.4 | -426 | -42 | -38 | -40 | -8.3 | -45 | -38 |
| Earnings per share | -0.44 | -1.44 | -0.14 | -0.13 | -0.13 | -0.03 | -0.14 | -0.12 |
| Balance sheet | ||||||||
| Total assets | 1,260 | 861 | 825 | 803 | 784 | 782 | 752 | 721 |
| Liabilities | 754 | 769 | 764 | 767 | 779 | 780 | 785 | 782 |
| Equity | 507 | 92 | 61 | 36 | 5.3 | 2.4 | -33 | -61 |
| Cash | 55 | 59 | 55 | 56 | 64 | 56 | 61 | 56 |
| Cash flow | ||||||||
| Operating cash flow | -31 | -44 | -29 | -19 | -19 | -45 | -36 | -38 |
| Capital expenditure | -1.6 | -1.4 | -0.6 | 0.1 | -0.9 | -3.0 | -1.6 | -1.0 |
| Free cash flow | -32 | -45 | -30 | -19 | -20 | -48 | -37 | -39 |
Value it:DCF calculatorMultiples calculator
Annual returns
Best year 2020 at +404.7%, weakest 2024 at −81.3%. 4 of 9 full years were positive. * partial year.
Quarterly reports
Filing date with the SEC and earnings per share of the quarter
| Day | Earnings per share |
|---|---|
| 5 Nov 2026 | −$0.12 |
| 6 Aug 2026 | −$0.14 |
| 8 May 2026 | −$0.03 |
| 25 Feb 2026 | −$0.13 |
| 6 Nov 2025 | −$0.13 |
| 7 Aug 2025 | −$0.14 |
| 12 May 2025 | −$1.44 |
| 17 Mar 2025 | −$0.44 |
| 12 Nov 2024 | −$0.22 |
| 9 Aug 2024 | −$0.64 |
| 9 May 2024 | −$0.29 |
| 28 Feb 2024 | −$0.31 |
Key metrics
Metrics of 15 Nov 2026; P/E, P/B, P/S, market cap and dividend yield at the last close.
Valuation
- Market cap
- €462m
- Market cap in trading currency
- $510m
- Enterprise value
- $311m
- P/E
- –
- P/S
- 3.16
- P/B
- –
- EV/Sales
- 1.92
- EV/EBITDA
- –
- Earnings yield
- –
- FCF yield
- -28.1%
Results (last four quarters)
- Revenue
- $161m
- Gross profit
- $55.5m
- EBITDA
- −$121m
- Net income
- −$131m
- Earnings per share
- −$0.42
- Revenue per share
- $0.52
- Revenue growth
- +5.5%
- Earnings growth
- –
Profitability
- Gross margin
- 34.4%
- Operating margin
- -81.3%
- Net margin
- -81.3%
- Return on equity
- –
- Return on assets
- -18.2%
Balance sheet and cash flow
- Cash
- $199m
- Cash per share
- $0.64
- Financial debt
- –
- Debt/equity %
- –
- Current ratio
- 4.62
- Book value per share
- −$0.20
- Operating cash flow
- −$137m
- Free cash flow
- −$143m
Dividend
- Dividend yield
- 0.00%
- Dividend (12 months)
- $0.00
- Yield (12 months)
- 0.00%
- Payout ratio
- –
- Ex-dividend date
- –
Shares and trading
- Shares outstanding
- 313m
- Volume
- 13.7m
- Avg. volume 3 months
- 12.7m
- Relative volume
- 1.0
Price and technicals
- Price
- $1.63
- 1 day
- −7.4%
- 52-week high
- $2.90
- 52-week low
- $1.11
- Distance to 52-week high
- −43.8%
- Distance to 52-week low
- +46.8%
- Distance to 50-day line
- −20.6%
- Distance to 200-day line
- +2.2%
- RSI (14)
- 35
- Volatility 1M
- 106.1%
Performance
- 1 week
- −16.8%
- 1 month
- −20.9%
- 3 months
- +27.3%
- 6 months
- +33.6%
- YTD
- −12.8%
- 1 year
- −7.4%
Dates
- Fiscal year end
- 31 Dec 2025
- Most recent quarter
- 30 Sep 2026
Frequently asked questions
How has PACB performed since 11/2016?
$10,000 grew to $2,071 by 20 Nov 2026, which is −14.6% per year. Distributions are reinvested; taxes and brokerage costs are not deducted.
How volatile is PACB?
Volatility was 90.1% per year, measured on monthly returns. The largest decline from a peak was −98.2%, with the low in 05/2025.
How does PACB compare with a broad equity ETF?
Over the same period Global equities (VT) returned +11.3% per year at 15.1% volatility, PACB returned −14.6% at 90.1%. The correlation of monthly returns was 0.32; 1 would mean they moved in lockstep.
Which currency are the figures in?
In US dollars, the currency of the US listing.